Han Y - Search Results

1

A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes.

Wu M, Lu J, Zhang L, Liu F, Chen S, Han Y, Zhao F, Guo K, Bao Y, Chen H, Jia W. Wu M, et al. Among authors: han y. Oncotarget. 2017 Oct 9;8(60):102550-102558. doi: 10.18632/oncotarget.21684. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254270 Free PMC article.

2

Hyperuricemia and overexcretion of uric acid increase the risk of simple renal cysts in type 2 diabetes.

Han Y, Zhang M, Lu J, Zhang L, Han J, Zhao F, Chen H, Bao Y, Jia W. Han Y, et al. Among authors: han j. Sci Rep. 2017 Jun 19;7(1):3802. doi: 10.1038/s41598-017-04036-6. Sci Rep. 2017. PMID: 28630500 Free PMC article. Clinical Trial.

3

Prevalence and Factors Associated With Bone Erosion in Patients With Gout.

Wu M, Liu FJ, Chen J, Chen L, Wei C, Hu ZM, Han Y, Lu JX, Jiang LX, Chen HB. Wu M, et al. Among authors: han y. Arthritis Care Res (Hoboken). 2019 Dec;71(12):1653-1659. doi: 10.1002/acr.23816. Arthritis Care Res (Hoboken). 2019. PMID: 30474923

4

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma.

Gao M, Chen G, Wang H, Xie B, Hu L, Kong Y, Yang G, Tao Y, Han Y, Wu X, Zhang Y, Dai B, Shi J. Gao M, et al. Among authors: han y. Oncotarget. 2016 May 17;7(20):29102-15. doi: 10.18632/oncotarget.8667. Oncotarget. 2016. PMID: 27074555 Free PMC article.

5

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.

Yang G, Gao M, Zhang Y, Kong Y, Gao L, Tao Y, Han Y, Wu H, Meng X, Xu H, Zhan F, Wu X, Shi J. Yang G, et al. Among authors: han y. Oncotarget. 2015 Sep 29;6(29):26982-94. doi: 10.18632/oncotarget.4831. Oncotarget. 2015. PMID: 26323098 Free PMC article.

6

High-pressure polymorphic transformation of rutile to alpha-PbO2-type TiO2 at {011}R twin boundaries.

Meng DW, Wu XL, Sun F, Huang LW, Liu F, Han YJ, Zheng JP, Meng X, Mason R. Meng DW, et al. Among authors: han yj. Micron. 2008;39(3):280-6. doi: 10.1016/j.micron.2007.07.001. Epub 2007 Jul 10. Micron. 2008. PMID: 17698363

7

[Inhibiting effect of CaMKIIN up-regulation on leukemia cells growth and its mechanism].

Hou J, Shi JM, Han Y, Hu XJ, Meng XQ. Hou J, et al. Among authors: han y. Zhonghua Xue Ye Xue Za Zhi. 2013 Dec;34(12):1006-9. doi: 10.3760/cma.j.issn.0253-2727.2013.12.002. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24369154 Chinese.

8

Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I.

Wu X, Shao Y, Tao Y, Ai G, Wei R, Meng X, Hou J, Han Y, Zhan F, Zheng J, Shi J. Wu X, et al. Among authors: han y. Biochem Biophys Res Commun. 2011 Nov 11;415(1):187-92. doi: 10.1016/j.bbrc.2011.10.057. Epub 2011 Oct 18. Biochem Biophys Res Commun. 2011. PMID: 22033416

9

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.

Wu X, Shi J, Wu Y, Tao Y, Hou J, Meng X, Hu X, Han Y, Jiang W, Tang S, Zangari M, Tricot G, Zhan F. Wu X, et al. Among authors: han y. Cancer Biol Ther. 2010 Dec 1;10(11):1201-14. doi: 10.4161/cbt.10.11.13669. Epub 2010 Dec 1. Cancer Biol Ther. 2010. PMID: 20953137 Free PMC article.

10

Aerosol particles released from grit chambers of nine urban wastewater treatment plants in typical regions: Fugitive characteristics, quantitative drivers, and generation process.

Wang W, Yang K, Li L, Han Y. Wang W, et al. Among authors: han y. Water Res. 2025 Jan 18;274:123162. doi: 10.1016/j.watres.2025.123162. Online ahead of print. Water Res. 2025. PMID: 39854778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,344 results

Search Page

Filters